COMP <GO>
BLK vs CME // DIVIDEND YIELD & FCF PAYOUT SAFETY
BlackRock Inc. (NYSE) VS. CME Group Inc. (NASDAQ) • 15-METRIC TALLY: BLK 6
— CME 6
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: CME
LAST: $1,176.24 (+1.59%) • MKT CAP: $182.16B
dividend-safety
0.00%
LAST: $296.42 (+0.81%) • MKT CAP: $106.10B
dividend-safety
3.71%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLK VS. CME)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLK | CME | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.20% | 3.50% | +2.70 | BLK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.4x | 40.2x | -10.80 | BLK | /valuation <GO> |
| Free Cash Flow Yield | 1.95% | 3.95% | -2.00 | CME | /fcf-yield <GO> |
| Operating Margin | 29.10% | 64.90% | -35.80 | CME | /operating-margins <GO> |
| Net Profit Margin | 22.90% | 62.50% | -39.60 | CME | /net-margins <GO> |
| Revenue Growth (YoY) | 18.70% | 6.40% | +12.30 | BLK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 3.71% | -3.71 | CME | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | CME | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.5 | 57.6 | +5.90 | BLK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 1.01 | +0.12 | BLK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 24.3x | +3.30 | CME | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $182.16B | $106.10B | $76.07B | BLK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLK REV | CME REV | BLK GROSS % | CME GROSS % | BLK FCF | CME FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.22B | $6.52B | — | — | $3.55B | $4.19B |
| FY 2024 | $20.41B | $6.13B | — | — | $4.70B | $3.60B |
| FY 2023 | $17.86B | $5.58B | — | — | $3.36B | $3.20B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLK // BETA 1.13
CME // BETA 1.01